Warning: The NCBI web site requires JavaScript to function. more...
Effect of montelukast on platelet activating factor- and tachykinin induced mucus secretion in the rat.
Schmidt R, Staats P, Groneberg DA, Wagner U.
J Occup Med Toxicol. 2008 Feb 20;3:5.
Related citations
Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
Hirayama Y, Lei YH, Barnes PJ, Rogers DF.
Br J Pharmacol. 1993 Mar;108(3):844-51.
'Sensory-efferent' neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro.
Ramnarine SI, Hirayama Y, Barnes PJ, Rogers DF.
Br J Pharmacol. 1994 Dec;113(4):1183-90.
The cysteinyl-leukotriene-1 receptor antagonist zafirlukast is a potent secretagogue in rat and human airways.
Eur J Pharmacol. 2005 Dec 19;527(1-3):150-6. Epub 2005 Nov 28.
Tachykinin control of ferret airways: mucus secretion, bronchoconstriction and receptor mapping.
Meini S, Mak JC, Rohde JA, Rogers DF.
Neuropeptides. 1993 Feb;24(2):81-9.
Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U, Fehmann H, Bredenbröker D, Klüber D, Lange A, Wichert P.
Neuropeptides. 1999 Feb;33(1):55-61.
Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigs.
Tsuchida H, Takahashi S, Nosaka E, Kuraya T, Yamashita M, Morimoto K.
Eur J Pharmacol. 2008 Oct 31;596(1-3):153-9. Epub 2008 Jul 31.
Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.
Phillips JE, Hey JA, Corboz MR.
Br J Pharmacol. 2003 Jan;138(1):254-60.
Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
Crimi N, Pagano C, Palermo F, Mastruzzo C, Prosperini G, Pistorio MP, Vancheri C.
J Allergy Clin Immunol. 2003 Apr;111(4):833-9.
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M, Imbe S, Sato R, Ikeda Y, Yamagata S, Iwanaga T, Tohda Y.
Int Immunopharmacol. 2009 Oct;9(11):1337-41. Epub 2009 Aug 23.
Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M, Kato M, Kimura H, Fujiu T, Morikawa A.
J Asthma. 2003 Jun;40(4):395-404.
Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig.
Corboz MR, Fernandez X, Rizzo CA, Tozzi S, Monahan ME, Hey JA.
Auton Autacoid Pharmacol. 2003 Feb;23(1):79-93.
Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
Ishimura M, Suda M, Morizumi K, Kataoka S, Maeda T, Kurokawa S, Hiyama Y.
Br J Pharmacol. 2008 Feb;153(4):669-75. Epub 2007 Nov 26.
Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
Liu YC, Khawaja AM, Rogers DF.
Br J Pharmacol. 1998 Jun;124(3):563-71.
Effect of non-peptide tachykinin NK(1) receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea.
Khawaja AM, Liu Y, Rogers DF.
Eur J Pharmacol. 1999 Nov 19;384(2-3):173-81.
Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST.
Thorax. 2002 Apr;57(4):323-7.
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, Seidenberg BC, Zwinderman AH, Peszek I, Sterk PJ.
Clin Exp Allergy. 1999 Jan;29(1):42-51.
Montelukast in pediatric asthma management.
Walia M, Lodha R, Kabra SK.
Indian J Pediatr. 2006 Apr;73(4):275-82. Review.
Tachykinin receptors mediating airway macromolecular secretion.
Gentry SE.
Life Sci. 1991;48(17):1609-18.
Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A, Ferland C, Tremblay GM, Laviolette M.
J Allergy Clin Immunol. 2006 Jul;118(1):113-9. Epub 2006 May 19.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on